Literature DB >> 12595458

Attenuated virulence of a Burkholderia cepacia type III secretion mutant in a murine model of infection.

Mladen Tomich1, Adam Griffith, Christine A Herfst, Jane L Burns, Christian D Mohr.   

Abstract

Type III secretion systems are utilized by a number of gram-negative bacterial pathogens to deliver virulence-associated proteins into host cells. Using a PCR-based approach, we identified homologs of type III secretion genes in the gram-negative bacterium Burkholderia cepacia, an important pulmonary pathogen in immunocompromised patients and patients with cystic fibrosis. One of the genes, designated bscN, encodes a member of a family of ATP-binding proteins believed to generate energy driving virulence protein secretion. Genetic dissection of the regions flanking the bscN gene revealed a locus consisting of at least 10 open reading frames, predicted to encode products with significant homology to known type III secretion proteins in other bacteria. A defined null mutation was generated in the bscN gene, and the null strain and wild-type parent strain were examined by use of a murine model of B. cepacia infection. Quantitative bacteriological analysis of the lungs and spleens of infected C57BL/6 mice revealed that the bscN null strain was attenuated in virulence compared to the parent strain, with significantly lower bacterial recovery from the lungs and spleens at 3 days postinfection. Moreover, histopathological changes, including an inflammatory cell infiltrate, were more pronounced in the lungs of mice infected with the wild-type parent strain than in those of mice infected with the isogenic bscN mutant. These results implicate type III secretion as an important determinant in the pathogenesis of B. cepacia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12595458      PMCID: PMC148827          DOI: 10.1128/IAI.71.3.1405-1415.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  57 in total

1.  Spa33, a cell surface-associated subunit of the Mxi-Spa type III secretory pathway of Shigella flexneri, regulates Ipa protein traffic.

Authors:  R Schuch; A T Maurelli
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

Review 2.  Type III export: new uses for an old pathway.

Authors:  G V Plano; J B Day; F Ferracci
Journal:  Mol Microbiol       Date:  2001-04       Impact factor: 3.501

3.  Cepacia syndrome occurring following prolonged colonisation with Burkholderia cepacia.

Authors:  C J Dobbin; R Soni; T Jelihovsky; P T Bye
Journal:  Aust N Z J Med       Date:  2000-04

4.  Characterization of the type III secretion locus of Bordetella pertussis.

Authors:  A Fauconnier; A Veithen; P Gueirard; R Antoine; L Wacheul; C Locht; A Bollen; E Godfroid
Journal:  Int J Med Microbiol       Date:  2001-03       Impact factor: 3.473

5.  Preferential adherence of cable-piliated burkholderia cepacia to respiratory epithelia of CF knockout mice and human cystic fibrosis lung explants.

Authors:  Umadevi Sajjan; Yijun Wu; Geraldine Kent; Janet Forstner
Journal:  J Med Microbiol       Date:  2000-10       Impact factor: 2.472

6.  Invasion of human type II pneumocytes by Burkholderia cepacia.

Authors:  P M Keig; E Ingham; K G Kerr
Journal:  Microb Pathog       Date:  2001-03       Impact factor: 3.738

7.  Intracellular survival of Burkholderia cepacia complex isolates in the presence of macrophage cell activation.

Authors:  L S Saini; S B Galsworthy; M A John; M A Valvano
Journal:  Microbiology       Date:  1999-12       Impact factor: 2.777

8.  Modulation of host immune responses, induction of apoptosis and inhibition of NF-kappaB activation by the Bordetella type III secretion system.

Authors:  M H Yuk; E T Harvill; P A Cotter; J F Miller
Journal:  Mol Microbiol       Date:  2000-03       Impact factor: 3.501

Review 9.  Assembly and function of type III secretory systems.

Authors:  G R Cornelis; F Van Gijsegem
Journal:  Annu Rev Microbiol       Date:  2000       Impact factor: 15.500

10.  Invasion and intracellular survival of Burkholderia cepacia.

Authors:  D W Martin; C D Mohr
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

View more
  28 in total

Review 1.  A decade of Burkholderia cenocepacia virulence determinant research.

Authors:  Slade A Loutet; Miguel A Valvano
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

2.  Computer-aided design of agents that inhibit the cep quorum-sensing system of Burkholderia cenocepacia.

Authors:  Kathrin Riedel; Manuela Köthe; Bernd Kramer; Wael Saeb; Astrid Gotschlich; Aldo Ammendola; Leo Eberl
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

3.  Immune Recognition of the Epidemic Cystic Fibrosis Pathogen Burkholderia dolosa.

Authors:  Damien Roux; Molly Weatherholt; Bradley Clark; Mihaela Gadjeva; Diane Renaud; David Scott; David Skurnik; Gregory P Priebe; Gerald Pier; Craig Gerard; Deborah R Yoder-Himes
Journal:  Infect Immun       Date:  2017-05-23       Impact factor: 3.441

4.  Burkholderia xenovorans LB400 harbors a multi-replicon, 9.73-Mbp genome shaped for versatility.

Authors:  Patrick S G Chain; Vincent J Denef; Konstantinos T Konstantinidis; Lisa M Vergez; Loreine Agulló; Valeria Latorre Reyes; Loren Hauser; Macarena Córdova; Luis Gómez; Myriam González; Miriam Land; Victoria Lao; Frank Larimer; John J LiPuma; Eshwar Mahenthiralingam; Stephanie A Malfatti; Christopher J Marx; J Jacob Parnell; Alban Ramette; Paul Richardson; Michael Seeger; Daryl Smith; Theodore Spilker; Woo Jun Sul; Tamara V Tsoi; Luke E Ulrich; Igor B Zhulin; James M Tiedje
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-09       Impact factor: 11.205

5.  Reconstitution of O-specific lipopolysaccharide expression in Burkholderia cenocepacia strain J2315, which is associated with transmissible infections in patients with cystic fibrosis.

Authors:  Ximena Ortega; Tracey A Hunt; Slade Loutet; Arlene D Vinion-Dubiel; Anup Datta; Biswa Choudhury; Joanna B Goldberg; Russell Carlson; Miguel A Valvano
Journal:  J Bacteriol       Date:  2005-02       Impact factor: 3.490

6.  Persistence of Burkholderia multivorans within the pulmonary macrophage in the murine lung.

Authors:  Karen K Chu; Kelly L MacDonald; Donald J Davidson; David P Speert
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

7.  The Burkholderia cepacia epidemic strain marker is part of a novel genomic island encoding both virulence and metabolism-associated genes in Burkholderia cenocepacia.

Authors:  Adam Baldwin; Pamela A Sokol; Julian Parkhill; Eshwar Mahenthiralingam
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

8.  Drosophila melanogaster as a model host for the Burkholderia cepacia complex.

Authors:  Josée Castonguay-Vanier; Ludovic Vial; Julien Tremblay; Eric Déziel
Journal:  PLoS One       Date:  2010-07-12       Impact factor: 3.240

9.  Transcriptional and posttranscriptional control of cable pilus gene expression in Burkholderia cenocepacia.

Authors:  Mladen Tomich; Christian D Mohr
Journal:  J Bacteriol       Date:  2004-02       Impact factor: 3.490

10.  Identification of potential therapeutic targets for Burkholderia cenocepacia by comparative transcriptomics.

Authors:  Deborah R Yoder-Himes; Konstantinos T Konstantinidis; James M Tiedje
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.